|
|
Latest Headlines
Xcelience and IriSys business alliance agreement strengthens regional access to CMC/Regulatory expertise
More...
| Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area
More...
| Xcelience and Penn Pharma Form a Joint Venture to Provide API Into Capsule Services in Europe and Asia Pacific Markets
More...
|
|
|
|
|
|
|
Case Studies
|
|
|
|
Case Study 3 Re-formulation and Process Improvement of a Labor Intensive and Expensive Manufacturing Process
|
|
The original process involved wet granulation and sugar coating and took approximately one-week to manufacture. The resultant product yielded varying dissolution profiles.
|
|
API comprises approximately 40% of the tablet. Initial direct compression resulted in poor weight uniformity and capping problems.
|
|
Xcelience statistically optimized the ingredients and their amounts to produce an elegant product which was successfully transferred to the manufacturing facility.
|
|
The reformulated product uses a direct compression and aqueous film coated process. It takes approximately 1.5 days to manufacture and yields a robust, rugged product, with reproducible and stable physical and chemical properties
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|